Class Actions

St. Jude Defibrillator Class Action —

This class action was brought on behalf of every person resident in Canada that was implanted with one of several specific models of the St. Jude Defibrillator (ICD), and their immediate family members.

Claims Administration Update

The claims administration is now completed, and the settlement funds were distributed to the Patient and Derivative class members during the week of June 14, 2021.  If you were expecting a payment, and have not received it, then please contact the Claims Administrator at:  info@stjudeicdclaim.ca or 1-833-414-8043, and be sure to reference your claim number.

The total number of approved explant claimants was approximately double the number of anticipated claimants, based upon the information that was provided to the plaintiff by St. Jude.

The referee also approved a large number of claims for complications arising from the explant surgery, which was unexpected, given the minor nature of the surgery for a change of defibrillator. The appeal judge also allowed a number of claims for survivors of individuals who had passed away.

The costs of the administration also were substantially higher than expected because of the substantial demands on their time by claimants in completing their claims.

As a result, the total amount that will be paid to each explant claimant without complications is much less than was expected.  Those eligible explant class members without complications will be receiving payments of $1,652.00 CAD.

While this is much less than was originally anticipated, it means that more affected persons are receiving compensation, and that those who suffered the greatest injuries are receiving the greatest amount of compensation.


Case Overview

This class action relates to the following of models St. Jude Defibrillator (ICD), manufactured between January 2010 and May 23, 2015:

  1. Fortify;
  2. Fortify Assura;
  3. Quadra Assura;
  4. Quadra Assura MP;
  5. Unify;
  6. Unify Assura; and,
  7. Unify Quadra. (the Patient Class)

For a full list of devices, please refer to the Long-Form Notice of Settlement Approval.

There are approximately 8,900 Patients in Canada who were implanted with one of the affected devices.

Health Canada issued a safety alert on October 15, 2016 warning of the risk of early battery depletion in these ICDs because the battery might form lithium clusters causing the battery to discharge rapidly.

The claim alleged that St. Jude Medical, Inc. knew of the potential for early battery depletion in the ICDs but delayed warning about the problem. St. Jude denies it was negligent or that it breached any duty owed to the Class.

Claims Administration Update

The claims administration is now completed, and the settlement funds were distributed to the Patient and Derivative class members during the week of June 14, 2021.  If you were expecting a payment, and have not received it, then please contact the Claims Administrator at:  info@stjudeicdclaim.ca or 1-833-414-8043, and be sure to reference your claim number.

The total number of approved explant claimants was approximately double the number of anticipated claimants, based upon the information that was provided to the plaintiff by St. Jude.

The referee also approved a large number of claims for complications arising from the explant surgery, which was unexpected, given the minor nature of the surgery for a change of defibrillator. The appeal judge also allowed a number of claims for survivors of individuals who had passed away.

The costs of the administration also were substantially higher than expected because of the substantial demands on their time by claimants in completing their claims.

As a result, the total amount that will be paid to each explant claimant without complications is much less than was expected.  Those eligible explant class members without complications will be receiving payments of $1,652.00 CAD.

While this is much less than was originally anticipated, it means that more affected persons are receiving compensation, and that those who suffered the greatest injuries are receiving the greatest amount of compensation.


Case Overview

This class action relates to the following of models St. Jude Defibrillator (ICD), manufactured between January 2010 and May 23, 2015:

  1. Fortify;
  2. Fortify Assura;
  3. Quadra Assura;
  4. Quadra Assura MP;
  5. Unify;
  6. Unify Assura; and,
  7. Unify Quadra. (the Patient Class)

For a full list of devices, please refer to the Long-Form Notice of Settlement Approval.

There are approximately 8,900 Patients in Canada who were implanted with one of the affected devices.

Health Canada issued a safety alert on October 15, 2016 warning of the risk of early battery depletion in these ICDs because the battery might form lithium clusters causing the battery to discharge rapidly.

The claim alleged that St. Jude Medical, Inc. knew of the potential for early battery depletion in the ICDs but delayed warning about the problem. St. Jude denies it was negligent or that it breached any duty owed to the Class.

We review every inquiry we receive and will respond promptly to case specific inquiries.
Contact us below and we’ll respond shortly.

Contact Us